Committee for Medicinal Products for Human Use and Alkermes News

This is selected news for Committee for Medicinal Products for Human Use and Alkermes, which are filed under Healthcare Topics and Capital Firms, respectively. There are 8 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
12/12/2019 Amgen’s Osteoporosis Drug Evenity Gets Approval in Europe
... risk of fracture. Zacks Rank & Key Picks Amgen currently carries a Zacks Rank 3 (Hold). A few better-ranked stocks in the biotech sector are Alkermes Plc. ( ALKS - Free Report ) , and Anika Therapeutics Inc. ( ANIK - Free Report ) , both sporting a Zacks Rank 1 (Strong Buy). You can see the complete ...
Zacks
11/20/2019 Biotech Stock Roundup: MYOV & KRTX Surge, Pipeline Updates From VRTX, CELG & More
It was a busy week for the biotech sector with updates from quite a few companies. Vertex Pharmaceuticals ( VRTX - Free Report ) announced positive data on its gene-editing therapy, while Celgene ( CELG - Free Report ) obtained a positive Committee for Medicinal Products for Human Use (CHMP) opinion for Revlimid in combination ...
Zacks
11/20/2019 Biotech Stock Roundup: MYOV & KRTX Surge, Pipeline Updates From VRTX, CELG & More
... hemoglobin at four months after the CTX001 infusion. Meanwhile, these studies are ongoing and patients will be followed for approximately two years following the infusion. Alkermes to Acquire Rodin Therapeutics : Alkermes plc ( ALKS - Free Report ) announced that it will acquire privately-held Rodin Therapeutics for an upfront cash payment of ...
Zacks
11/20/2019 Biotech Stock Roundup: MYOV & KRTX Surge, Pipeline Updates From VRTX, CELG & More
... sector with updates from quite a few companies. Vertex Pharmaceuticals VRTX announced positive data on its gene-editing therapy, while Celgene CELG obtained a positive Committee for Medicinal Products for Human Use (CHMP) opinion for Revlimid in combination with Rituxan for the treatment of adult patients with previously treated follicular ...
Yahoo News
11/19/2019 Celgene’s Revlimid-Rituximab Combo Gets Positive CHMP Opinion
... Zacks Rank & Other Stocks to Consider Celgene currently has a Zacks Rank 2 (Buy). A few other top-ranked stocks in the biotech sector are Alkermes Plc. ALKS and Anika Therapeutics Inc. ANIK, both sporting a Zacks Rank 1 (Strong Buy). You can see the complete list of today's Zacks ...
Yahoo News
11/18/2019 Celgene’s Revlimid-Rituximab Combo Gets Positive CHMP Opinion
... you like to follow? Zacks Equity Research Cancel Read More Hide Full Article Celgene Corporation ( CELG - Free Report ) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the approval of Revlimid (lenalidomide) in combination with Roche Holding AG's ...
Zacks
11/18/2019 Celgene’s Revlimid-Rituximab Combo Gets Positive CHMP Opinion
... Zacks Rank & Other Stocks to Consider Celgene currently has a Zacks Rank 2 (Buy). A few other top-ranked stocks in the biotech sector are Alkermes Plc. ( ALKS - Free Report ) and Anika Therapeutics Inc. ( ANIK - Free Report ) , both sporting a Zacks Rank 1 (Strong Buy). You can see the complete ...
Zacks